Generate a tailored SOP for Dr. Chengcan Yao. Improve your application with a focused, well-structured draft.
Chengcan Yao studies the roles of bioactive lipids in the modulation of immunity related to inflammatory diseases in barrier tissues. His research focuses on the cellular and molecular mechanisms by which lipid mediators influence the barrier immune system, particularly in the context of inflammation. Yao's work aims to develop improved treatments for complex degenerative inflammatory conditions at barrier sites. He is currently concentrating on the classic inflammatory eicosanoid, prostaglandin E2 (PGE2), and has published articles related to this area.
Department of Marketing